Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.

Reset
4290 results found

Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sezary syndrome

Gao, C; McCormack, C; van der Weyden, C; Goh, MS; Campbell, BA; Twigger, R; Buelens, O; Harrison, SJ; Khoo, C; Lade, S; Prince, HM

(2019), Blood, 1346-1350

DOI: 10.1182/blood.2019000765

Maintaining a fit T-cell compartment: lymphoma treatment sequencing in the era of chimeric antigen receptor T-cell therapies

Dickinson, M; Weinkove, R

(2019), Intern. Med. J., 1338-1338

DOI: 10.1111/imj.14453

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

Rashidi, A; Hamadani, M; Zhang, MJ; Wang, HL; Abdel-Azim, H; Aljurf, M; Assal, A; Bajel, A; Bashey, A; Battiwalla, M; Beitinjaneh, AM; Bejanyan, N; Bhatt, VR; Bolanos-Meade, J; Byrne, M; Cahn, JY; Cairo, M; Ciurea, S; Copelan, E; Cutler, C; Daly, A; Diaz, MA; Farhadfar, N; Gale, RP; Ganguly, S; Grunwald, MR; Hahn, T; Hashmi, S; Hildebrandt, GC; Holland, HK; Hossain, N; Kanakry, CG; Kharfan-Dabaja, MA; Khera, N; Koc, Y; Lazarus, HM; Lee, JW; Maertens, J; Martino, R; McGuirk, J; Munker, R; Murthy, HS; Nakamura, R; Nathan, S; Nishihori, T; Palmisiano, N; Patel, S; Pidala, J; Olin, R; Olsson, RF; Oran, B; Ringden, O; Rizzieri, D; Rowe, J; Savoie, ML; Schultz, KR; Seo, S; Shaffer, BC; Singh, A; Solh, M; Stockerl-Goldstein, K; Verdonck, LF; Wagner, J; Waller, EK; De Lima, M; Sandmaier, BM; Litzow, M; Weisdorf, D; Romee, R; Saber, W

(2019), Blood Adv., 1826-1836

DOI: 10.1182/bloodadvances.2019000050

Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations

Birkinshaw, RW; Gong, JN; Luo, CS; Lio, D; White, CA; Anderson, MA; Blombery, P; Lessene, G; Majewski, IJ; Thijssen, R; Roberts, AW; Huang, DCS; Colman, PM; Czabotar, PE

(2019), Nat. Commun.

DOI: 10.1038/s41467-019-10363-1

A Retrospective Evaluation of Risk of Peripartum Cardiac Dysfunction in Survivors of Childhood, Adolescent and Young Adult Malignancies

Chait-Rubinek, L; Mariani, JA; Goroncy, N; Herschtal, A; Wheeler, GC; Dwyer, MK; Seymour, JF; Campbell, BA

(2019), Cancers

DOI: 10.3390/cancers11081046

Pediatric aplastic anemia treatment patterns and responses; power in the numbers

Fox, LC; Ritchie, DS

(2019), Haematologica, 1909-1912

DOI: 10.3324/haematol.2019.225870

Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression

Seymour, JF; Marcus, R; Davies, A; Gallop-Evans, E; Grigg, A; Haynes, A; Herold, M; Illmer, T; Nilsson-Ehle, H; Sokler, M; Dunzinger, U; Nielsen, T; Launonen, A; Hiddemann, W

(2019), Haematologica, 1202-1208

DOI: 10.3324/haematol.2018.209015

Further Examining the TROG 99.03 Trial in Early-Stage Follicular Lymphoma: Cure Rate and the Role of Positron Emission Tomography Reply

MacManus, M; Fisher, R; McClure, B; Seymour, JF

(2019), J. Clin. Oncol., 257-+

DOI: 10.1200/JCO.2018.18.01309

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

Bachy, E; Seymour, JF; Feugier, P; Offner, F; Lopez-Guillermo, A; Belada, D; Xerri, L; Catalano, JV; Brice, P; Lemonnier, F; Martin, A; Casasnovas, O; Pedersen, LM; Dorvaux, V; Simpson, D; Leppa, S; Gabarre, J; da Silva, MG; Glaisner, S; Ysebaert, L; Vekhoff, A; Intragumtornchai, T; Le Gouill, S; Lister, A; Estell, JA; Milone, G; Sonet, A; Farhi, J; Zeuner, H; Tilly, H; Salles, G

(2019), J. Clin. Oncol., 2815-+

DOI: 10.1200/JCO.19.01073

Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study

Kater, AP; Seymour, JF; Hillmen, P; Eichhorst, B; Langerak, AW; Owen, C; Verdugo, M; Wu, J; Punnoose, EA; Jiang, YW; Wang, J; Boyer, M; Humphrey, K; Mobasher, M; Kipps, TJ

(2019), J. Clin. Oncol., 269-+

DOI: 10.1200/JCO.18.01580

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia

Mehta, RS; Holtan, SG; Wang, T; Hemmer, MT; Spellman, SR; Arora, M; Couriel, DR; Alousi, AM; Pidala, J; Abdel-Azim, H; Ahmed, I; Aljurf, M; Askar, M; Auletta, JJ; Bhatt, V; Bredeson, C; Chhabra, S; Gadalla, S; Gajewski, J; Gale, RP; Gergis, U; Hematti, P; Hildebrandt, GC; Inamoto, Y; Kitko, C; Khandelwal, P; MacMillan, ML; Majhail, N; Marks, DI; Mehta, P; Nishihori, T; Olsson, RF; Pawarode, A; Diaz, MA; Prestidge, T; Qayed, M; Rangarajan, H; Ringden, O; Saad, A; Savani, BN; Seo, S; Shah, A; Shah, N; Schultz, KR; Solh, M; Spitzer, T; Szer, J; Teshima, T; Verdonck, LF; Williams, KM; Wirk, B; Wagner, J; Yared, JA; Weisdorf, DJ

(2019), Blood Adv., 1441-1449

DOI: 10.1182/bloodadvances.2018030171

The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia

Minson, AG; Cummins, K; Fox, L; Costello, B; Yeung, D; Cleary, R; Forsyth, C; Tatarczuch, M; Burbury, K; Motorna, O; Shortt, J; Fleming, S; McQuillan, A; Schwarer, A; Harrup, R; Holmes, A; Ratnasingam, S; Chan, KL; Hsu, WH; Ashraf, A; Putt, F; Grigg, A

(2019), Blood Adv., 1084-1091

DOI: 10.1182/bloodadvances.2018028035

Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial

Zelenetz, AD; Salles, G; Mason, KD; Casulo, C; Le Gouill, S; Sehn, LH; Tilly, H; Cartron, G; Chamuleau, MED; Goy, A; Tam, CS; Lugtenburg, PJ; Petrich, AM; Sinha, A; Samineni, D; Herter, S; Ingalla, E; Szafer-Glusman, E; Klein, C; Sampath, D; Kornacker, M; Mobasher, M; Morschhauser, F

(2019), Blood, 1964-1976

DOI: 10.1182/blood-2018-11-880526

Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL

Tam, CS; Trotman, J; Opat, S; Burger, JA; Cull, G; Gottlieb, D; Harrup, R; Johnston, PB; Marlton, P; Munoz, J; Seymour, JF; Simpson, D; Tedeschi, A; Elstrom, R; Yu, YL; Tang, ZY; Han, L; Huang, J; Novotny, W; Wang, L; Roberts, AW

(2019), Blood, 851-859

DOI: 10.1182/blood.2019001160

Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables

Roberts, AW; Ma, S; Kipps, TJ; Coutre, SE; Davids, MS; Eichhorst, B; Hallek, M; Byrd, JC; Humphrey, K; Zhou, L; Chyla, B; Nielsen, J; Potluri, J; Kim, SY; Verdugo, M; Stilgenbauer, S; Wierda, WG; Seymour, JF

(2019), Blood, 111-122

DOI: 10.1182/blood.2018882555

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia

Blombery, P; Anderson, MA; Gong, JN; Thijssen, R; Birkinshaw, RW; Thompson, ER; Teh, CE; Nguyen, T; Xu, Z; Flensburg, C; Lew, TE; Majewski, IJ; Gray, DHD; Westerman, DA; Tam, CS; Seymour, JF; Czabotar, PE; Huang, DCS; Roberts, AW

(2019), Cancer Discov., 342-353

DOI: 10.1158/2159-8290.CD-18-1119

Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma

Brighton, TA; Khot, A; Harrison, SJ; Ghez, D; Weiss, BM; Kirsch, A; Magen, H; Gironella, M; Oriol, A; Streetly, M; Kranenburg, B; Qin, X; Bandekar, R; Hu, P; Guilfoyle, M; Qi, M; Nemat, S; Goldschmidt, H

(2019), Clin. Cancer Res., 3772-3775

DOI: 10.1158/1078-0432.CCR-18-3470

The Journal in 2018

Szer, J

(2019), Intern. Med. J., 7-8

DOI: 10.1111/imj.14189

Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative

Mehta, A; Kuter, DJ; Salek, SS; Belmatoug, N; Bembi, B; Bright, J; vom Dahl, S; Deodato, F; Di Rocco, M; Goker-Alpan, O; Hughes, DA; Lukina, EA; Machaczka, M; Mengel, E; Nagral, A; Nakamura, K; Narita, A; Oliveri, B; Pastores, G; Perez-Lopez, J; Ramaswami, U; Schwartz, IV; Szer, J; Weinreb, NJ; Zimran, A

(2019), Intern. Med. J., 578-591

DOI: 10.1111/imj.14156

Role of bone marrow biopsy for fever of unknown origin in the contemporary Australian context

Hong, FS; Fox, LC; Chai, KL; Htun, K; Clucas, D; Morgan, S; Cole-Sinclair, MF; Juneja, S

(2019), Intern. Med. J., 850-854

DOI: 10.1111/imj.14147

Revisiting acquired aplastic anaemia: current concepts in diagnosis and management

Clucas, DB; Fox, LC; Wood, EM; Hong, FS; Gibson, J; Bajel, A; Szer, J; Blombery, P; McQuilten, ZK; Hiwase, D; Firkin, F; Cole-Sinclair, MF; Firkin, F; Badoux, X; Bajel, A; Blombery, P; Cole, C; Cole-Sinclair, M; Fox, L; Forsyth, C; Gibson, J; Hiwase, D; Hong, F; Johnston, A; McQuilten, Z; Mills, T; Opat, S; Roncolato, F; Szer, J; Wood, E

(2019), Intern. Med. J., 152-159

DOI: 10.1111/imj.14140

Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma

Blombery, P; Birkinshaw, RW; Nguyen, T; Gong, JN; Thompson, ER; Xu, Z; Westerman, DA; Czabotar, PE; Dickinson, M; Huang, DCS; Seymour, JF; Roberts, AW

(2019), Br. J. Haematol., E188-E191

DOI: 10.1111/bjh.16069

Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance

Wight, JC; Yue, M; Keane, C; Johnston, A; Linton, K; Chin, C; Wai, SH; Talaulikar, D; Gasiorowski, R; Cheah, CY; Gregory, GP; Dickinson, M; Minson, A; Coombes, C; Ku, M; Lam, S; Hawkes, EA

(2019), Br. J. Haematol., 174-184

DOI: 10.1111/bjh.16064

Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first-line immunochemotherapy

Jamois, C; Gibiansky, E; Gibiansky, L; Buchheit, V; Sahin, D; Cartron, G; Marcus, R; Hiddemann, W; Seymour, JF; Strefford, JC; Hargreaves, CE; Meneses-Lorente, G; Frey, N; Fingerle-Rowson, G

(2019), Br. J. Clin. Pharmacol., 1495-1506

DOI: 10.1111/bcp.13920

Management of patients with follicular lymphoma treated first line with obinutuzumab

Opat, S; Dickinson, M; Cheah, CY; Tam, C; Boulos, J; Thorburn, AN; Trotman, J

(2019), Asia-Pac. J. Clin. Oncol., 3-11

DOI: 10.1111/ajco.13153

Mechanisms, mishaps and manipulation of iron uptake

Bennett, C; Pasricha, SR

(2019), Hemasphere, 104-108

DOI: 10.1097/HS9.0000000000000237

Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study

Papanicolaou, GA; Ustun, C; Young, JAH; Chen, M; Kim, S; Ahn, KW; Komanduri, K; Lindemans, C; Auletta, JJ; Riches, ML; Abdel-Azim, H; Ahmed, IA; Aljurf, M; Antin, J; Ballen, KK; Beitinjaneh, A; Brown, VI; Cerny, J; Champlin, R; Chao, N; Chhabra, S; Dahi, PB; Daly, A; Dandoy, C; Dvorak, CC; Forman, S; Freytes, C; Ganguly, S; Hashmi, SK; Kharfan-Dabaja, MA; Lazarus, H; Ljungman, P; Malone, AK; Murthy, G; Nishihori, T; Page, K; Pingali, R; Reddy, V; Saad, A; Savani, BN; Seftel, M; Szer, J; Vij, R; Weisdorf, D; William, BM; Williams, K; Wirk, B; Yared, J; Yu, LC

(2019), Clin. Infect. Dis., 1771-1779

DOI: 10.1093/cid/ciz031

High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia - lessons for immunopathogenesis and prescribing

Meher-Homji, Z; Tam, CS; Siderov, J; Seymour, JF; Holmes, NE; Chua, KYL; Phillips, EJ; Slavin, MA; Trubiano, JA

(2019), Leuk. Lymphoma, 3455-3460

DOI: 10.1080/10428194.2019.1633640

Where do we currently stand with T-cell prolymphocytic leukemia?

Khot, A

(2019), Leuk. Lymphoma, 563-565

DOI: 10.1080/10428194.2018.1551543

Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma

Agarwal, R; Chan, YC; Tam, CS; Hunter, T; Vassiliadis, D; Teh, CE; Thijssen, R; Yeh, P; Wong, SQ; Ftouni, S; Lam, EYN; Anderson, MA; Pott, C; Gilan, O; Bell, CC; Knezevic, K; Blombery, P; Rayeroux, K; Zordan, A; Li, J; Huang, DCS; Wall, M; Seymour, JF; Gray, DHD; Roberts, AW; Dawson, MA; Dawson, SJ

(2019), Nat. Med., 119-+

DOI: 10.1038/s41591-018-0243-z

89 90 91 92 93 94 95 96 97